Screening for prostate cancer;Screening beim prostatakarzinom

Onkologie

Volumn 21, Issue 6, 1998, Pages 521-524

  Holtl W ^a  

^a Urologische Universitatsklinik   (Austria)

Author keywords

Early detection; Prostate cancer; Screening

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

CANCER DIAGNOSIS; CANCER SCREENING; COST; EARLY DIAGNOSIS; HUMAN; LABORATORY TEST; MALE; PHYSICAL EXAMINATION; PROSTATE CANCER; REVIEW;

EID: 0032444791     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000026896     Document Type: Review

References (26)

1. Goldstein MM, Messing EM: Prostate and bladder screening. J Am Coll Surg 1998;186:63-74.
2. Rosenthal DS: Changing trends. CA Cancer J Clin 1988;48:3-9.
3. Boyle P, Napalkov P, Barry MJ, Bishop DT, Correa R, Gu FL, Guess H, Jacobsen S, Kiemeney LA, Nagy G, O'Leary M, Padley R, Pontes E, Richard F, Saitoh M, Vesey SG: Epidemiology and natural history of prostate cancer; in Murphy G (ed): First International Consultation on Prostate Cancer, Monaco 1996. Proc SCI 1997, pp 1-29.
4. Coley CM, Barry MJ, Fleming C, Mulley AG: Early detection of prostate cancer - part I: Prior probability and effectiveness of tests. Ann Intern Med 1997; 126:394-406.
5. Woolf SH: Screening for prostate cancer with prostate specific antigen. An examination of the evidence. N Engl J Med 1995;333:1401-1405.
6. Coley CM, Barry MJ, Mulley AG: Screening for prostate cancer: Clinical Guideline part III. Ann Intern Med 1997;126:480-484.
7. Schröder FH: The European screening study for prostate cancer. Can J Oncol 1994;4(suppl 1): 102-105.
8. Gohagan JK, Prorok PC, Kramer BS, Cornell JE: Prostate cancer screening in the lung, colorectal and ovarian screening trial of the National Cancer Institute. J Urol 1994;152:1905-1909.
9. Mettlin C, Murphy GP, Lee F, Littrup PJ, Chesley A, Babaian R, Badalament R, Kane RA, Mostofi FK, and the Investigators of the American National Cancer Society Prostate Cancer Detection Project J Urol 1994;152:1737-1740.
10. Labrie F, Candas B, Cusan L, Gomez JL, Diamond P, Suburu R, Lemay M: Diagnosis of advanced or noncurable prostate cancer can be practically eliminated by prostate specific antigen. Urology 1996; 47:212-217.
11. Xia Z, Jacobsen SJ, Bergstralh EJ, Chute CG, Katusic SK, Lieber MM: Secular changes in radical prostatectomy utilization in Olmsted County, Minnesota 1980-1995. J Urol 1998;159:904-908.
12. Landis SH, Murray T, Bolden S, Wingo PA: Cancer Statistics, 1998. Cancer J Clin 1998;48:6-29.
13. Gunby P: Conference seeks to provide basis for prostate cancer guidance message. JAMA 1995;274: 1103-1106.
14. Miller AB, Chamberlain J, Day NE, Hakama K, Prorok PC: Report on a workshop of the UICC project on evaluation for screening. Int J Cancer 1990;46:761-769.
15. Richie JP, Kavoussi LR, Ho GT, O'Donnell MA, St Laurent D, Chen A, Goldstein DS, Loughlin KR: Prostate cancer screening: The role of digital rectal examination and prostate-specific antigen. Ann Surg Oncol 1994;1:117-120.
16. Bostwick DG: Gleason grading of prostatic needle biopsy. Correlation with grade in 316 matched prostatectomies. Am J Surg Pathol 1994;18:796-803.
17. Spires SE, Cibull ML, Wood DP, Miller S, Spires SM, Banks ER: Gleason histologic grading in prostatic carcinoma. Correlation of 18-gauge core biopsy with radical prostatectomy. Arch Pathol Lab Med 1994;118:705-708.
18. Pedersen KV, Carlsson P, Varenhorst E, Lofman O, Berglund K: Screening of carcinoma of the prostate by digital rectal examination in a randomly selected population. Br Med J 1990;300:1041-1044.
19. Gustafsson O, Norming U, Almgard LE, Frederiksson A, Gustavsson G, Harvig B: Diagnostic methods in the detection of prostate cancer: A study of randomly selected population of 2400 men. J Urol 1992;148:1827-1831.
20. Oesterling JE: A critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 1991;145:907.
21. Mettlin CJ, Lee F, Drago J: The American Cancer Society National Prostate Cancer Detection project: Findings on the detection of early prostate cancer in 2425 men. Cancer 1991;67:2949.
22. Babaian RJ, Mettlin CJ, Kane R: The relationship of prostate specific antigen to digital rectal examination and transrectal ultrasonogaphy. Cancer 1992;69: 1195-1200.
23. Catalona WJ, Smith DS, Ornstein DK: Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/ml and benign prostate examination: Enhancement of specificity with free PSA measurements. JAMA 1997;277:1452-1455.
24. Steinberg GD, Bales GT, Brendler CB: An analysis of watchful waiting for clinically localized prostate cancer. J Urol 1998;159:1431-1436.
25. Carter BH, Pearson JD: PSA velocity for the diagnosis of early prostate cancer. Urol Clin North Am 1993;20:665-670.
26. McLaren DB, McKenzie M, Duncan G, Pickles T: Watchful waiting or watchful progression? Prostate specific antigen doubling times and clinical behavior in patients with early untreated prostate carcinoma. Cancer 1998;82:342-348.